Candel Therapeutics, Inc. (CADL) Ownership

$5.26

$0.24 (4.78%)
Last update: 04:00 PM EST
Day's range
$4.97
Day's range
$5.32

Candel Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 8.23 M $41.99 M   0.00% 15.99%
ACORN CAPITAL ADVISORS, LLC 11/17/2025 2.58 M $13.16 M   0.00% 5.01%
BLACKROCK, INC. 11/12/2025 2.38 M $12.13 M   3.37% 4.62%
VANGUARD GROUP INC 11/07/2025 2.01 M $10.24 M   12.28% 3.90%
PORTOLAN CAPITAL MANAGEMENT, LLC 11/13/2025 1.38 M $7.06 M   -14.65% 2.69%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 928.20 K $4.73 M   2.68% 1.80%
HALTER FERGUSON FINANCIAL INC. 10/09/2025 698.00 K $3.56 M   -10.11% 1.36%
STATE STREET CORP 11/14/2025 688.77 K $3.51 M   5.64% 1.34%
SANDS CAPITAL VENTURES, LLC 11/13/2025 405.84 K $2.07 M   0.00% 0.79%
NORTHERN TRUST CORP 11/14/2025 306.78 K $1.56 M   6.57% 0.60%
CITADEL ADVISORS LLC 11/14/2025 252.29 K $1.29 M   100.00% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 223.82 K $1.14 M   -36.65% 0.43%
NUVEEN, LLC 11/12/2025 209.66 K $1.07 M   126.71% 0.41%
TANAGER WEALTH MANAGEMENT LLP 10/24/2025 198.18 K $1.01 M   0.79% 0.38%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 137.89 K $703.23 K   59.88% 0.27%
MILLENNIUM MANAGEMENT LLC 11/14/2025 136.67 K $697.02 K   100.00% 0.27%
TWO SIGMA INVESTMENTS, LP 11/14/2025 136.12 K $694.19 K   -63.13% 0.26%
CITADEL ADVISORS LLC 11/14/2025 123.90 K $631.89 K   -59.51% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 121.00 K $617.12 K   6.36% 0.24%
JANE STREET GROUP, LLC 11/14/2025 110.40 K $563.04 K   -24.54% 0.21%
MARSHALL WACE, LLP 11/13/2025 103.85 K $529.62 K   -35.69% 0.20%
BANK OF NEW YORK MELLON CORP 11/03/2025 94.57 K $482.30 K   8.95% 0.18%
UBS GROUP AG 11/13/2025 94.07 K $479.76 K   14.49% 0.18%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 93.70 K $477.87 K   -43.18% 0.18%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 82.22 K $419.00 K   0.76% 0.16%
KOVITZ INVESTMENT GROUP PARTNERS, LLC 11/10/2025 79.32 K $404.51 K   100.00% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 78.80 K $401.88 K   -33.16% 0.15%
MORGAN STANLEY 11/14/2025 75.94 K $387.30 K   -33.22% 0.15%
ALLIANCEBERNSTEIN L.P. 11/14/2025 69.11 K $352.46 K   0.00% 0.13%
LIDO ADVISORS, LLC 11/14/2025 60.20 K $307.03 K   100.00% 0.12%
BIRCHVIEW CAPITAL, LP 11/13/2025 60.00 K $306.00 K   0.00% 0.12%
BARCLAYS PLC 11/12/2025 59.60 K $303.93 K   -12.92% 0.12%
HB WEALTH MANAGEMENT, LLC 10/23/2025 58.35 K $297.56 K   100.00% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 55.10 K $281.01 K   0.00% 0.11%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2025 54.05 K $275.64 K   100.00% 0.11%
RHUMBLINE ADVISERS 11/06/2025 53.64 K $273.56 K   -1.57% 0.10%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 49.48 K $252.36 K   100.00% 0.10%
BANK OF AMERICA CORP /DE/ 11/14/2025 47.64 K $242.98 K   -34.85% 0.09%
MONETA GROUP INVESTMENT ADVISORS LLC 11/14/2025 40.52 K $206.64 K   0.00% 0.08%
GOLDMAN SACHS GROUP INC 11/14/2025 36.02 K $183.71 K   -54.64% 0.07%
CITADEL ADVISORS LLC 11/14/2025 33.30 K $169.83 K   -11.44% 0.06%
SQUAREPOINT OPS LLC 11/14/2025 30.96 K $157.91 K   -16.21% 0.06%
JANNEY MONTGOMERY SCOTT LLC 10/27/2025 30.39 K $155.00 K   11.34% 0.06%
DEUTSCHE BANK AG\ 11/13/2025 26.66 K $135.96 K   23.28% 0.05%
WELLS FARGO & COMPANY/MN 11/13/2025 26.31 K $134.19 K   26.65% 0.05%
ALPS ADVISORS INC 11/05/2025 26.28 K $134.02 K   -2.84% 0.05%
STRATOS WEALTH ADVISORS, LLC 11/06/2025 23.00 K $117.30 K   0.00% 0.04%
RAYMOND JAMES FINANCIAL INC 11/14/2025 22.16 K $113.04 K   0.00% 0.04%
LPL FINANCIAL LLC 11/12/2025 21.40 K $109.16 K   -68.48% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 11/12/2025 20.55 K $104.80 K   -13.92% 0.04%

Candel Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 98 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 8.23 M

ACORN CAPITAL ADVISORS, LLC: 2.58 M

BlackRock, Inc.: 2.38 M

VANGUARD GROUP INC: 2.01 M

Portolan Capital Management, LLC: 1.38 M

GEODE CAPITAL MANAGEMENT, LLC: 928,197

43.99% of Candel Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 25.57 M shares in the last 24 months. This purchase volume represents approximately $134.51 M in transactions.